U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 065245
Company: FRESENIUS KABI USA
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CEFTRIAXONE CEFTRIAXONE SODIUM EQ 250MG BASE/VIAL INJECTABLE;INTRAMUSCULAR, INTRAVENOUS Discontinued None No No
CEFTRIAXONE CEFTRIAXONE SODIUM EQ 500MG BASE/VIAL INJECTABLE;INTRAMUSCULAR, INTRAVENOUS Discontinued None No No
CEFTRIAXONE CEFTRIAXONE SODIUM EQ 1GM BASE/VIAL INJECTABLE;INTRAMUSCULAR, INTRAVENOUS Discontinued None No No
CEFTRIAXONE CEFTRIAXONE SODIUM EQ 2GM BASE/VIAL INJECTABLE;INTRAMUSCULAR, INTRAVENOUS Discontinued None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/15/2006 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
08/04/2011 SUPPL-5 Labeling-Package Insert, Labeling-Package Insert

Label is not available on this site.

06/03/2010 SUPPL-3 Labeling-Package Insert

Label is not available on this site.

04/21/2009 SUPPL-2 Labeling

Label is not available on this site.

01/16/2009 SUPPL-1 Labeling

Label is not available on this site.

Back to Top